Clinical Trials
6 results for Prostate Cancer
UTSW SBRT Prospective Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation
- Condition: Cancer Patients Receiving Stereotactic Body RTX
- Intervention: Radiation: SBRT
- Study ID: NCT02170181
The Role of Stereotactic Body Radiotherapy in the Management of Castration-Resistant Prostate Cancer With Oligometastases: An Adaptive Phase II/III Randomized Trial.
- Condition: Castration-resistant Prostate Cancer Patients With Oligometastases
- Intervention: Drug: Leuprolide Acetate, Drug: Goserelin Acetate, Drug: Triptorelin, Drug: Enzalutamide, Radiation: Stereotactic Body Radiation Therapy
- Study ID: NCT02685397
A Randomized Phase III Trial of Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer [PLATON]
- Condition: Prostate Cancer Metastatic
- Intervention: Radiation: Ablative Radiation Therapy, Other: Standard of care
- Study ID: NCT03784755
Oligomet-DK. National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients
- Condition: Prostate Cancer Metastatic
- Intervention: Procedure: RARP, Radiation: SBRT, Drug: ADT
- Study ID: NCT04086290
Fluciclovine (FACBC) PET/CT Site-Directed Therapy of Oligometastatic Prostate Cancer (Flu-BLAST-PC)
- Condition: Prostate Adenocarcinoma, PSA Level Greater Than or Equal to 0.5, PSA Level Less Than Ten
- Study ID: NCT04175431
Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy
- Condition: Prostate Cancer
- Study ID: NCT04302454